"The current Tolerable Daily Intake (TDI) level for BPA is adequately justified."
"… the ingestion of BPA via food does not present a risk to consumers"
"Receipts containing BPA do not pose a risk to consumers or cashiers"
"Levels of BPA in the human body are very low, indicating that BPA is not accumulated in the body and is rapidly eliminated."
"Receipts containing BPA do not pose a risk to consumers or cashiers"
"… the ingestion of BPA via food does not present a risk to consumers"
"Levels of BPA in the human body are very low, indicating that BPA is not accumulated in the body and is rapidly eliminated."
"[…] the scientific evidence at this time does not suggest that the very low levels of human exposure to BPA through the diet are unsafe."
The EU Risk Assessment on bisphenol A (BPA) concluded that BPA and BPA-based products are safe. EU Risk Assessments are one element in the EU's Existing Substances Regulation to evaluate and control risks of chemical substances, one of the pre-cursors to REACH. They are widely recognised as the world's most rigorous scientific assessment of a substance's safety in existence today.
In the updated 2008 Risk Assessment Report on BPA published in June 2008, the European Commission concluded that products made from BPA, such as polycarbonate plastic and epoxy resins, are safe for consumers and the environment when used as intended.
For the BPA Risk Assessment independent scientific experts from the EU Members States considered several hundreds of studies that appeared during recent years, among them both small exploratory studies that do not follow established protocols, as well as comprehensive, statistically-robust studies following accepted international protocols and standards, such as the Good Laboratory Practice Directive. Overall, the studies also covered all potentially affected age groups of consumers including babies and small children.
The latest BPA Risk Assessment conclusion is consistent with conclusions of the scientific assessments of other regulatory bodies including the U.S. Food and Drug Administration (FDA) and the Japanese Ministry of Health, Labour and Welfare.
More information